EAM Investors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Sell |
1,454,328
-323,583
| -18% | -$1.18M | 0.8% | 30 |
|
|
2025
Q1 | $3.41M | Buy |
+1,777,911
| New | +$3.41M | 0.59% | 72 |
|
|
2024
Q2 | – | Sell |
-428,549
| Closed | -$784K | – | 247 |
|
|
2024
Q1 | $784K | Buy |
+428,549
| New | +$784K | 0.12% | 207 |
|
|
2020
Q3 | – | Sell |
-201,521
| Closed | -$2.74M | – | 270 |
|
|
2020
Q2 | $2.74M | Buy |
+201,521
| New | +$2.74M | 0.61% | 35 |
|
|
2018
Q1 | – | Sell |
-180,503
| Closed | -$2.68M | – | 285 |
|
|
2017
Q4 | $2.68M | Sell |
180,503
-54,967
| -23% | -$817K | 0.48% | 71 |
|
|
2017
Q3 | $4.63M | Buy |
235,470
+12,330
| +6% | +$243K | 0.62% | 37 |
|
|
2017
Q2 | $3.21M | Buy |
+223,140
| New | +$3.21M | 0.53% | 58 |
|
|
2016
Q1 | – | Sell |
-380,433
| Closed | -$4.92M | – | 295 |
|
|
2015
Q4 | $4.92M | Buy |
380,433
+138,993
| +58% | +$1.8M | 0.64% | 13 |
|
|
2015
Q3 | $2.33M | Buy |
+241,440
| New | +$2.33M | 0.37% | 122 |
|